2020年欧洲甲状腺协会在良性甲状腺结节中使用图像引导消融的临床实践指南

2020-09-01 欧洲甲状腺协会 Eur Thyroid J . 2020 Jul;9(4):172-185

需要进行干预的良性甲状腺病变的标准治疗方法是手术,或者对于自主功能的甲状腺结节(AFTN)进行手术或放射碘治疗。越来越多地提出以图像引导的热消融(TA)程序作为针对特定临床状况的治疗选择。由于越来越多

中文标题:

2020年欧洲甲状腺协会在良性甲状腺结节中使用图像引导消融的临床实践指南

英文标题:

2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules

发布机构:

欧洲甲状腺协会

发布日期:

2020-09-01

简要介绍:

需要进行干预的良性甲状腺病变的标准治疗方法是手术,或者对于自主功能的甲状腺结节(AFTN)进行手术或放射碘治疗。越来越多地提出以图像引导的热消融(TA)程序作为针对特定临床状况的治疗选择。由于越来越多的科学证据和广泛的可用性,ETA认为有必要制定成人患者使用TA的指南。 TA手术的耐受性良好,但需要对操作员进行专门培训,并且需要与患者分享可能的并发症信息。在观察,手术和甲状腺良性结节的TA之间权衡时,应考虑以下因素。在固态非功能性结节中,TA引起甲状腺结节体积减少,同时症状得到改善。随着时间的流逝,结节可能会重新生长,并可能需要与患者对话进行重复治疗或手术。在AFTN中,放射性碘是一线治疗,但对于AFTN较小的年轻患者,可考虑使用TA,因为恢复正常甲状腺功能的可能性更高,并且避免放射。在囊性结节中,乙醇消融(EA)是最有效和最便宜的治疗方法。对于在EA后复发或在引流和EA后有明显残留固体成分的囊性病变,可以考虑使用TA。应将TA限于引起症状或美观的良性病变。目前,激光和射频消融是最彻底评估的技术,具有相似的令人满意的临床效果。微波和高强度聚焦超声治疗方案仍有待充分评估。

相关资料下载:
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=03b2b1c0019698d4, title=2020年欧洲甲状腺协会在良性甲状腺结节中使用图像引导消融的临床实践指南, enTitle=2020 European Thyroid Association Clinical Practice Guideline for the Use of Image-Guided Ablation in Benign Thyroid Nodules, guiderFrom=Eur Thyroid J . 2020 Jul;9(4):172-185, authorId=0, author=, summary=需要进行干预的良性甲状腺病变的标准治疗方法是手术,或者对于自主功能的甲状腺结节(AFTN)进行手术或放射碘治疗。越来越多地提出以图像引导的热消融(TA)程序作为针对特定临床状况的治疗选择。由于越来越多, cover=, journalId=0, articlesId=null, associationId=483, associationName=欧洲甲状腺协会, associationIntro=欧洲甲状腺协会(European Thyroid Association ETA)成立于1965年,此后每年定期举行一次国际甲状腺会议,会员资格等级分为荣誉会员、普通会员、初级会员、团体会员、合作会员、高级会员六类,目前有600余名会员。旨在推动甲状腺学(基础和临床)及甲状腺病学的发展。, copyright=0, guiderPublishedTime=Tue Sep 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>需要进行干预的良性甲状腺病变的标准治疗方法是手术,或者对于自主功能的甲状腺结节(AFTN)进行手术或放射碘治疗。越来越多地提出以图像引导的热消融(TA)程序作为针对特定临床状况的治疗选择。由于越来越多的科学证据和广泛的可用性,ETA认为有必要制定成人患者使用TA的指南。 TA手术的耐受性良好,但需要对操作员进行专门培训,并且需要与患者分享可能的并发症信息。在观察,手术和甲状腺良性结节的TA之间权衡时,应考虑以下因素。在固态非功能性结节中,TA引起甲状腺结节体积减少,同时症状得到改善。随着时间的流逝,结节可能会重新生长,并可能需要与患者对话进行重复治疗或手术。在AFTN中,放射性碘是一线治疗,但对于AFTN较小的年轻患者,可考虑使用TA,因为恢复正常甲状腺功能的可能性更高,并且避免放射。在囊性结节中,乙醇消融(EA)是最有效和最便宜的治疗方法。对于在EA后复发或在引流和EA后有明显残留固体成分的囊性病变,可以考虑使用TA。应将TA限于引起症状或美观的良性病变。目前,激光和射频消融是最彻底评估的技术,具有相似的令人满意的临床效果。微波和高强度聚焦超声治疗方案仍有待充分评估。</p>, tagList=[TagDto(tagId=736, tagName=甲状腺), TagDto(tagId=7217, tagName=甲状腺结节)], categoryList=[CategoryDto(categoryId=23, categoryName=普通外科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5072, appHits=241, showAppHits=0, pcHits=700, showPcHits=4831, likes=1, shares=13, comments=12, approvalStatus=1, publishedTime=Sun Sep 13 13:49:06 CST 2020, publishedTimeString=2020-09-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sun Sep 13 13:45:41 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 19:58:14 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击:
评论区 (10)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1005128, encodeId=c0151005128a2, content=哇哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Wed Aug 04 14:55:21 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968159, encodeId=94ad96815982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cb95505023, createdName=ms8000000438948492, createdTime=Mon May 24 15:12:57 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944873, encodeId=77ca9448e3dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Tue Mar 02 18:37:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944772, encodeId=09ac944e7228, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:44:49 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915316, encodeId=b1159153168e, content=天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b55451559, createdName=理想15279388401, createdTime=Sun Jan 10 18:19:35 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-08-04 黄威龙

    哇哦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1005128, encodeId=c0151005128a2, content=哇哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Wed Aug 04 14:55:21 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968159, encodeId=94ad96815982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cb95505023, createdName=ms8000000438948492, createdTime=Mon May 24 15:12:57 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944873, encodeId=77ca9448e3dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Tue Mar 02 18:37:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944772, encodeId=09ac944e7228, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:44:49 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915316, encodeId=b1159153168e, content=天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b55451559, createdName=理想15279388401, createdTime=Sun Jan 10 18:19:35 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-05-24 ms8000000438948492

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1005128, encodeId=c0151005128a2, content=哇哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Wed Aug 04 14:55:21 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968159, encodeId=94ad96815982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cb95505023, createdName=ms8000000438948492, createdTime=Mon May 24 15:12:57 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944873, encodeId=77ca9448e3dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Tue Mar 02 18:37:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944772, encodeId=09ac944e7228, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:44:49 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915316, encodeId=b1159153168e, content=天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b55451559, createdName=理想15279388401, createdTime=Sun Jan 10 18:19:35 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-03-02 1471d48dm72暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1005128, encodeId=c0151005128a2, content=哇哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Wed Aug 04 14:55:21 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968159, encodeId=94ad96815982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cb95505023, createdName=ms8000000438948492, createdTime=Mon May 24 15:12:57 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944873, encodeId=77ca9448e3dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Tue Mar 02 18:37:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944772, encodeId=09ac944e7228, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:44:49 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915316, encodeId=b1159153168e, content=天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b55451559, createdName=理想15279388401, createdTime=Sun Jan 10 18:19:35 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-03-02 ms5000002046462755

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1005128, encodeId=c0151005128a2, content=哇哦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210728/ef0965c7185541efa3305a2a0ebf560f/882e5df91b1d4be4b745ce3c279f526b.jpg, createdBy=a4765556053, createdName=黄威龙, createdTime=Wed Aug 04 14:55:21 CST 2021, time=2021-08-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=968159, encodeId=94ad96815982, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4cb95505023, createdName=ms8000000438948492, createdTime=Mon May 24 15:12:57 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944873, encodeId=77ca9448e3dd, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=43ff5192496, createdName=1471d48dm72暂无昵称, createdTime=Tue Mar 02 18:37:24 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=944772, encodeId=09ac944e7228, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6d095409783, createdName=ms5000002046462755, createdTime=Tue Mar 02 13:44:49 CST 2021, time=2021-03-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915316, encodeId=b1159153168e, content=天天向上, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=69b55451559, createdName=理想15279388401, createdTime=Sun Jan 10 18:19:35 CST 2021, time=2021-01-10, status=1, ipAttribution=)]
    2021-01-10 理想15279388401

    天天向上

    0